Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceuticals U.S.A., Inc.”

20 pharma patents match "Takeda Pharmaceuticals U.S.A., Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 20
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 20 pharmaceutical patents matching "Takeda Pharmaceuticals U.S.A., Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

20 results for “Takeda Pharmaceuticals U.S.A., Inc.” · 30,257 patents in full index Clear search

  1. US 9937157

    Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted
  2. US 9889152

    Multiple PPI dosage form

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  3. US 9889125

    Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  4. US 9255063

    Colchicine solid-state forms; methods of making; and methods of use thereof

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  5. US 9248119

    Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  6. US 9238029

    Multiple PPI dosage form

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  7. US 9233103

    Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  8. US 9107912

    Methods for concomitant treatment of theophylline and febuxostat

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  9. US 8841333

    Methods for treating nephrolithiasis

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  10. US 8785491

    Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  11. US 8519002

    Colchicine solid complex; methods of making; and methods of use thereof

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  12. US 8497290

    Thiocolchicine derivatives, method of making and methods of use thereof

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted
  13. US 8461187

    Multiple PPI dosage form

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted
  14. US 8445541

    Methods for concomitant administration of colchicine and a second active agent

    Takeda Pharmaceuticals U.S.A., Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  15. US 8440722

    Methods for concomitant administration of colchicine and a second active agent

    Takeda Pharmaceuticals U.S.A., Inc. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  16. US 8440721

    Methods for concomitant administration of colchicine and a second active agent

    Takeda Pharmaceuticals U.S.A., Inc. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  17. US 8415396

    Colchine compositions and methods

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted
  18. US 8415395

    Colchicine compositions and methods

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted
  19. US 8372872

    Methods for concomitant treatment of theophylline and febuxostat

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  20. US 8173158

    Methods of treating gastrointestinal disorders independent of the intake of food

    Takeda Pharmaceuticals U.S.A., Inc. · Granted May 8, 2012 · Expires May 3, 2032

    granted